Transdermal Drug Delivery System Market Share, Growth, Demand and Forecast 2032

Transdermal Drug Delivery System Industry Prospective:

The global Transdermal Drug Delivery System market size accrued earnings worth approximately USD 33.32 Billion in 2023 and is predicted to gain revenue of about USD 49.60 Billion by 2032, is set to record a CAGR of nearly 4.52% over the period from 2024 to 2032.

The study includes the drivers and restraints of the transdermal drug delivery system market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the transdermal drug delivery system market on a global level.

Request Free Sample

Transdermal Drug Delivery System Market: Overview

Transdermal drug delivery systems deliver drugs via the skin to ensure a systemic drug circulation and maintain clinically effective concentrations at a predetermined rate over an estimated timeline. The substantial advancements in the biotechnology industry and improving capabilities of medical practitioners who use drugs at a target location without causing skin rupture is enabling the worldwide acceptance of transdermal drug delivery systems as the preferred drug administrating route worldwide.

The rising occurrences of chronic diseases and various technological developments in healthcare, pharmaceutical, and biotechnology sectors are boosting the transdermal drug delivery system market globally. A plethora of applications of these systems are witnessed in pain management, hormonal disorders, cardiovascular diseases, and central nervous system ailments, which will generate lucrative growth avenues for the transdermal drug delivery system market in the years ahead. Beneficial features like non-invasiveness, lower pain sensations in patients, complete administration of a dose, and ease of treatment termination are also driving this market.

Growing geriatric population base and escalating patient population suffering from chronic disorders, such as diabetes, angina, and hypertension, are likely to fuel the transdermal drug delivery system market expansion in the future. Moreover, the surging adoption rate of latest delivery system technologies like ultrasound is also boosting this market. However, these drug delivery systems have various disadvantages like irritation at the application site and edema, which may impede this global market.

In order to give the users of this report a comprehensive view of the transdermal drug delivery system market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

Transdermal Drug Delivery System Market: Segmentation

The transdermal drug delivery system market is fragmented based on type, application, and end-user.

By type, the market is divided into transdermal semisolids and transdermal patches. The transdermal patches are further segmented into reservoir membrane patches, matrix patches, drug-in-adhesive patches, and microneedle patches. The transdermal semisolids further include sprays, ointments, and gels.

By application, the transdermal drug delivery system market includes cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and others.

The end-user segment of the market for transdermal drug delivery system is bifurcated into hospitals and clinics and home care settings.

Transdermal Drug Delivery System Market: Report Scope

Transdermal Drug Delivery System Market: Regional Analysis

North America accounted for the largest share in the global transdermal drug delivery system market in 2018 and is anticipated to remain dominant over the forecast time period as well. The Asia Pacific transdermal drug delivery system market is expected to register the highest growth rate globally in the future.

Transdermal Drug Delivery System Market: Competitive Analysis

The global transdermal drug delivery system market is led by players like:

• GlaxoSmithKline
• Novartis
• Johnson & Johnson
• Endo International
• Purdue Pharma
• Boehringer Ingelheim
• Hisamitsu Pharmaceutical
• Bristol-Myers Squibb
• Mylan
• Bayer

This report segments the global transdermal drug delivery system market into:

Global Transdermal Drug Delivery System Market: Type Analysis

• Transdermal Patches
  • Drug-In-Adhesive Patches
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
• Transdermal Semisolids
  • Gels
  • Ointments
  • Sprays

Global Transdermal Drug Delivery System Market: Application Analysis

• Pain Management
• Hormonal Applications
  • Testosterone Replacement Therapy
  • Transdermal Estrogen Therapy
• Central Nervous System Disorders
• Cardiovascular Diseases
• Other Applications

Global Transdermal Drug Delivery System Market: End-User Analysis

• Hospitals and Clinics
• Home Care Settings

Global Transdermal Drug Delivery System Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa